DR. ASHRAF ZARIF BADROS, M.D.
Osteopathic Medicine in Baltimore, MD

License number
Maryland D42593
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
22 S. Greene St, Baltimore, MD 21263
Phone
(410) 328-1230
(410) 328-1975 (Fax)

Personal information

See more information about ASHRAF ZARIF BADROS at radaris.com
Name
Address
Phone
Ashraf Badros, age 62
4305 Norwood Rd, Baltimore, MD 21218
Ashraf Z Badros, age 62
4305 Norwood Ave, Baltimore, MD 21218
(410) 554-3836

Professional information

Ashraf Z Badros Photo 1

Ashraf Z Badros, Baltimore MD

Specialties:
Transplant Surgery, Medical Oncology, Hematology & Oncology
Work:
University of Maryland
22 S Greene St, Baltimore, MD 21263 Univ. of Maryland Oncology Associates Pa
419 W Redwood St, Baltimore, MD 21201
Education:
Ain Shams University (1985)


Ashraf Z Badros Photo 2

Dr. Ashraf Z Badros, Baltimore MD - MD (Doctor of Medicine)

Specialties:
Oncology, Medical Oncology
Address:
UNIVERSITY OF MARYLAND MEDICAL CENTER
22 S Greene St, Baltimore 21201
(410) 328-6971 (Phone), (410) 328-8326 (Fax)
University Maryland Cancer Ctr
22 S Greene St SUITE 1, Baltimore 21201
(410) 328-7450 (Phone)
Greenebaum Cancer Center
22 S Greene St SUITE N9E12, Baltimore 21201
(410) 328-1230 (Phone)
Certifications:
Internal Medicine, 1993, Medical Oncology, 1995
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
UNIVERSITY OF MARYLAND MEDICAL CENTER
22 S Greene St, Baltimore 21201
University Maryland Cancer Ctr
22 S Greene St SUITE 1, Baltimore 21201
Greenebaum Cancer Center
22 S Greene St SUITE N9E12, Baltimore 21201
Baltimore Washington Medical Center
301 Hospital Dr, Glen Burnie 21061
University of Maryland Medical Center
22 South Greene St, Baltimore 21201
Education:
Medical School
Ain Shams University, Faculty Of Medicine
Graduated: 1985
Georgetown University Hospital
Harbor Hospital Center


Ashraf Zarif Badros Photo 3

Ashraf Zarif Badros, Baltimore MD

Specialties:
Oncologist
Address:
22 S Greene St, Baltimore, MD 21201
Education:
Doctor of Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)


Ashraf Badros Photo 4

Methods Of Using Saha And Bortezomib For Treating Multiple Myeloma

US Patent:
2010011, May 6, 2010
Filed:
Nov 2, 2007
Appl. No.:
12/312163
Inventors:
Ashraf Z. Badros - Baltimore MD, US
International Classification:
A61K 31/69, A61P 35/00
US Classification:
514 64
Abstract:
The present invention relates to a method of treating cancer in a subject in need thereof, by administering to a subject in need thereof a first amount of a histone deacetylase (HDAC) inhibitor such as suberoylanilide hydroxamic acid (SAHA), or a pharmaceutically acceptable salt or hydrate thereof, and a second amount of one or more anti-cancer agents, including Bortezomib. The HDAC inhibitor and the anti-cancer agent may be administered to comprise therapeutically effective amounts. In various aspects, the effect of the HDAC inhibitor and the anti-cancer agent may be additive or synergistic.